Catalysts for Sciegen Pharmaceuticals Inc

DILTIAZEM HYDROCHLORIDE — FDA approval

OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval

DESOXIMETASONE — FDA approval

DESOXIMETASONE — FDA approval

RELGAABI (GABAPENTIN) — FDA approval

GABAPENTIN — FDA approval

ATORVASTATIN CALCIUM — FDA approval

BUPROPION HYDROCHLORIDE — FDA approval

TICAGRELOR — FDA approval

GABAPENTIN — FDA approval

RELGAABI (GABAPENTIN) — FDA approval

RELGAABI (GABAPENTIN) — FDA approval

RELGAABI (GABAPENTIN) — FDA approval

GABAPENTIN — FDA approval

GABAPENTIN — FDA approval

GABAPENTIN — FDA approval

BUPROPION HYDROCHLORIDE — FDA approval

DILTIAZEM HYDROCHLORIDE — FDA approval

ATORVASTATIN CALCIUM — FDA approval

ATORVASTATIN CALCIUM — FDA approval

BUPROPION HYDROCHLORIDE — FDA approval

BUPROPION HYDROCHLORIDE — FDA approval

BUPROPION HYDROCHLORIDE — FDA approval

ATORVASTATIN CALCIUM — FDA approval

ATORVASTATIN CALCIUM — FDA approval

RELGAABI (GABAPENTIN) — FDA approval

RELGAABI (GABAPENTIN) — FDA approval

RELGAABI (GABAPENTIN) — FDA approval

RELGAABI (GABAPENTIN) — FDA approval

RELGAABI (GABAPENTIN) — FDA approval